Acid Reflux vs. GERD: What is the difference?

Health & Lifestyle
404

Listen to article (english)

Translate to Spanish or other 102 languages!

Acid reflux occurs when stomach acid travels back up the esophagus. It affects many people occasionally. Gastroesophageal reflux disease (GERD) is a chronic condition in which acid reflux becomes frequent, causing persistent or severe symptoms. Image for illustration purposes
Acid reflux occurs when stomach acid travels back up the esophagus. It affects many people occasionally. Gastroesophageal reflux disease (GERD) is a chronic condition in which acid reflux becomes frequent, causing persistent or severe symptoms. Image for illustration purposes

Medical News Today

- Advertisement -

Acid reflux occurs when stomach acid travels back up the esophagus. It affects many people occasionally. Gastroesophageal reflux disease (GERD) is a chronic condition in which acid reflux becomes frequent, causing persistent or severe symptoms.

Doctors can diagnose GERD based on a person’s symptoms. They may also run tests to rule out other potential causes of acid reflux.

Follow the link below to read the full story on Medical News Ttoday:

- Advertisement -

https://www.medicalnewstoday.com/articles/acid-reflux-vs-gerd?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-04-19&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Pharr Ems First Responders Honored with Hometown Heroes Award
Next article
Promoting Careers in The Hospital Setting to Roma High School 

More Articles

What Persistent Fatigue Might Be Telling You

Mega Doctor News CLEVELAND CLINIC - We’ve all had those days where we’re...

AMA Unveils New Initiative to Boost Nutrition Education Nationwide

The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

The Silent Toll of Substance Use on Today’s Young Adults

Mega Doctor News by University of Michigan Newswise - Young adults who heavily use substances...
- Advertisement -